| Literature DB >> 30858787 |
Marcello Albanesi1, Carlo Pasculli1, Lucia Giliberti1, Maria Pia Rossi1, Danilo Di Bona1, Maria Filomena Caiaffa2, Luigi Macchia1.
Abstract
INTRODUCTION: Onion (Allium cepa) handling can induce contact dermatitis, rhinoconjunctivitis and asthma. However, only sporadic reports exist on allergic reactions to onion consumption. AIM: We describe herein a case of a 35-year-old man who had an episode of anaphylaxis following cooked onion ingestion. We evaluated onion-specific IgE, the possible cross-reactivity between onion and peach and lymphocyte proliferation in response to onion.Entities:
Keywords: IgE-ELISA inhibition; food allergy; lipid transfer proteins; lymphocyte proliferation; onion allergy
Year: 2019 PMID: 30858787 PMCID: PMC6409889 DOI: 10.5114/ada.2019.82829
Source DB: PubMed Journal: Postepy Dermatol Alergol ISSN: 1642-395X Impact factor: 1.837
Figure 1Evaluation of onion-specific IgE. A – Quantitative skin prick tests for a commercially available array of food allergens. B – Quantitative skin prick tests for a commercially available onion extract and semi-purified in-house onion extract; prick tests with raw and cooked onion, raw garlic and M. comosum; C – circulating food allergen-specific IgE, as measured by ImmunoCAP. The Skin Index represents the ratio between the area of the allergen wheal and the area of the exogenous histamine reference wheal
Figure 2Evaluation of onion cross-reactivity. A – Circulating LTP-specific IgE as measured by ImmunoCAP. B – IgE-ELISA inhibition by onion proteins. Serum of the patient was incubated for 24 h at 4°C with the indicated amount of onion protein from an in-house extract. C – IgE-ELISA inhibition by peach proteins. Serum of the patient was incubated for 24 h at 4°C with the indicated amount of peach protein from an in-house extract. D – All c 3 and Pru p 3 amino acid sequence identity. Vertical lines between the two sequences indicate the identical amino acid residues
Figure 3Onion-specific B-cell proliferation. A – Gating strategy for CD 19 and CD 3 cells. Representative CD 19+ (B) and CD 3+ (C) cell proliferation assessed by reduction of CFSE intensity for the patient compared to healthy controls. Experiments were done in triplicates